Regulatory PathRegulatory requirements compared

Active substances

Omeprazole + Sodium bicarbonate

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
Byraza Plus40,1100 mg,mgCapsule · Oral use28 BlisterSAR 87.50Generic · PrescriptionAlrazi Pharmaceutical Industries Factory CoValid
Byraza Plus20,1100 mg,mgCapsule, hard · Oral use28 BlisterSAR 43.75Generic · PrescriptionAlrazi Pharmaceutical Industries Factory CoValid
GASTROZOLE PLUS 20 MG/1100 MG CAPSULE20,1100 mg,mgCapsule · Oral use28 BottleSAR 50.15Generic · PrescriptionRIYADH PHARMAValid
GASTROZOLE PLUS 40/1100 MG CAPSULES40,1100 mg,mgCapsule · Oral use28 BottleSAR 114.00Generic · PrescriptionRIYADH PHARMAValid
OMIZ PLUS 20MG CAPSULE20,1100 mg,mgCapsule · Oral use28 BlisterSAR 52.80Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyValid
OMIZ PLUS 40MG CAPSULE40,1100 mg,mgCapsule · Oral use28 BlisterSAR 120.10Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyValid
Omeprex Plus40,1100 mg,mgCapsule · Oral use30 BlisterSAR 93.75Generic · PrescriptionSAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL COValid
Omezyn Plus40,1100 mg,mgCapsule, hard · Oral use28 BlisterSAR 92.65Generic · PrescriptionOMAN PHARMACEUTICAL PRODUCTSValid
Risek Plus40,1100 mg,mgCapsule · Oral use30 BottleSAR 89.20Generic · PrescriptionGulf Pharmaceutical Industries (Julphar)Valid
SoiCarby40,1100 mg,mgCapsule, hard · Oral use28 BlisterSAR 87.50Generic · PrescriptionALPHA PHARMA INDUSTRYValid
Indications — CHI Daman Drug Formulary

BACTRIAL INFECTIONS OF THE GASTROINTESTINAL TRACT- H-PYLORI ERADICATION-EVIDENCE BASED FIRST LINE TREATMENT STRATEGY; BACTRIAL INFECTIONS OF THE GASTROINTESTINAL TRACT- H-PYLORI ERADICATION-SALVAGE THERAPIES; BARIATRIC SURGERY; DYSPEPSIA; GASTROESOPHAGEAL REFLUX DISEASE (GERD); MIGRAINE/ HEADACHE; PEPTIC ULCER

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
ZEGERID OTC20MG;1.1GMcapsule · oralRILEY CONSUMEROver-the-counter1 Dec 2009
OMEPRAZOLE AND SODIUM BICARBONATE20MG/PACKET;1.68GM/PACKET; 40MG/PACKET;1.68GM/PACKETfor suspension · oralSTRIDES PHARMA INTLPrescription19 Apr 2013
ZEGERID OTC20MG/PACKET;1.68GM/PACKETfor suspension · oralRILEY CONSUMEROver-the-counter17 Jun 2013
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GMcapsule · oralPERRIGO R AND DOver-the-counter15 Jul 2016
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GM; 40MG;1.1GMcapsule · oralDR REDDYSPrescription15 Jul 2016
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GM; 40MG;1.1GMcapsule · oralAJANTA PHARMA LTDPrescription15 Jul 2016
OMEPRAZOLE AND SODIUM BICARBONATE20MG/PACKET;1.68GM/PACKET; 40MG/PACKET;1.68GM/PACKETfor suspension · oralAJANTA PHARMA LTDPrescription27 Jul 2016
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GM; 40MG;1.1GMcapsule · oralAUROLIFE PHARMA LLCPrescription19 Aug 2016
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GMcapsule · oralAUROBINDO PHARMAOver-the-counter7 Nov 2016
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GM; 40MG;1.1GMcapsule · oralSCIEGEN PHARMSPrescription6 Dec 2016
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GMcapsule · oralZYDUSOver-the-counter16 Mar 2018
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GM; 40MG;1.1GMcapsule · oralZYDUS PHARMSPrescription25 May 2018
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GM; 40MG;1.1GMcapsule · oralADAPTISPrescription30 Apr 2020
KONVOMEP2MG/ML;84MG/MLfor suspension · oralAZURITYPrescription30 Aug 2022
OMEPRAZOLE AND SODIUM BICARBONATE20MG/PACKET;1.68GM/PACKETfor suspension · oralDR REDDYSOver-the-counter9 May 2024
OMEPRAZOLE AND SODIUM BICARBONATE20MG/PACKET;1.68GM/PACKET; 40MG/PACKET;1.68GM/PACKETfor suspension · oralNOVITIUM PHARMAPrescription10 Dec 2025
ZEGERID20MG/PACKET;1.68GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 40MG/PACKET;1.68GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**for suspension · oralSALIXDiscontinued15 Jun 2004
ZEGERID40MG/PACKET;1.68GM/PACKETfor suspension · oralSANTARUSDiscontinued21 Dec 2004
ZEGERID20MG;1.1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 40MG;1.1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**capsule · oralSALIXDiscontinued27 Feb 2006
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GM; 40MG;1.1GMcapsule · oralSTRIDES PHARMA INTLDiscontinued25 May 2010
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GMcapsule · oralSTRIDES PHARMA INTLDiscontinued15 Jul 2016
OMEPRAZOLE AND SODIUM BICARBONATE20MG;1.1GMcapsule · oralCHARTWELL RXDiscontinued15 Jul 2016

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACKONVOMEP 2-84 MG/ML ORAL SUSP$2.085per ML23 Sep 2026
US NADACKONVOMEP 2-84 MG/ML ORAL SUSP$1.762per ML23 Sep 2026
US NADACKONVOMEP 2-84 MG/ML ORAL SUSP$1.2442per ML23 Sep 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.